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Gene Description  Symbol  Initial 
MSC 
Expanded 
MSC  0.1 kPa  1 kPa  11 kPa  34 kPa  1 kPa  11 kPa  34kPa  
Inhibitors Added                Bleb  Bleb  Bleb 
Normalization  Actin  Actin  Actin  Actin  Actin  Actin  Actin  Actin  Actin  Actin 
ATP-binding cassette G2  ABCG2  0.60  0.51  0.31  0.42  0.58  0.14  0.50  0.62  0.56 
Alpha-Fetoprotein  AFP  0.29  0.23  0.18  0.31  0.45  0.04  0.21  0.26  0.25 
CD44 Antigen  CD44  0.03  0.12  0.15  0.26  0.16  0.13  0.03  0.05  0.05 
TAP Binding Protein  TAPBP  0.25  0.30  0.39  0.42  0.52  0.22  0.18  0.32  0.15 
CD9 Antigen (p24)  CD9  0.20  0.21  0.64  0.66  0.66  0.18  0.21  0.28  0.38 
Integrin, Alpha 1  ITGA1  0.70  0.51  0.20  0.19  0.16  0.34  0.21  0.23  0.27 
Integrin, Alpha 2  ITGA2  0.23  0.21  0.43  0.41  0.11  0.15  0.27  0.21  0.19 
Integrin, Alpha 3  ITGA3  0.26  0.42  0.22  0.33  0.30  0.25  0.19  0.29  0.23 
Integrin, Alpha 4  ITGA4  0.06  0.07  0.37  0.45  0.54  0.08  0.03  0.25  0.10 
Ig Interleukin 1 Receptor  IL-1R  0.25  0.22  0.50  0.55  0.41  0.09  0.27  0.23  0.16 
Interleukin 2 Receptor, Alpha  IL-2R  0.14  0.14  0.66  0.56  0.38  0.28  0.33  0.25  0.17 
Interleukin 6 Receptor  IL6R  0.33  0.28  0.66  0.69  0.67  0.37  0.40  0.38  0.27 
CD34 Antigen  CD34  0.03  0.05  0.13  0.12  0.15  0.11  0.03  0.09  0.04 
Tyrosine Phospho. Receptor C  CD45  0.12  0.20  0.25  0.26  0.26  0.18  0.15  0.15  0.11 
Table  S1.  Oligonucleotide  array  profiles  for  genes  indicating  mesenchymal  origin.  RNA  levels  were 
obtained for initially isolated MSCs (passage 4) as well as MSCs expanded in culture (up to passage 12).  
MSCs from these groups were plated onto 0.1, 1, 11, and 34kPa matrices, grown for 7 days with or without 
blebbistatin,  and  also  profiled.  Raw  data  was  normalized  by  total  actin  levels  and  ranges  from  0  (no 
expression)  to  1  (maximal  expression).  Bold,  italicized  genes  indicate  markers  that  are  not  generally 
expressed in the native stem cell population (Pittenger et al., 1999), i.e. – normalized expression in initially 
isolated  MSCs  <  ~0.15.  Note  that  there  is  not  a  dramatic  RNA  change  between  initially  isolated  and 
expanded MSCs but there are significant expression changes once plated on a compliant gel surface. 
 
 
Media #  Description  Formulation 
MSC GM  MSC Growth Media  Low Glucose DMEM + 20% FBS + 
1% Penicillin/Streptomycin 
MSC MIM  Myoblast Induction Media (MIM)  Low Glucose DMEM + 20% FBS + 
1% Penicillin/Streptomycin + 
100nM Dexamethasone + 
50µM Hydrocortisone 
MSC OIM  Osteoblast Induction Media (OIM)  45% Hank’s F12 + 45% α-MEM + 10% FBS 
+ 50µM ascorbate-2-phosphate + 10mM β-
glycerol phosphate  + 
100nM Dexamethasone 
C2C12 GM 
FC7 GM 
 
C2C12 Growth Media (GM) 
 
78% High Glucose DMEM + 20% FBS + 
1% Chicken Embryo Extract + 
1% Penicillin/Streptomycin 
hFOB GM  hFOB Growth Media (GM)  45% Hank’s F12 + 45% DMEM + 10% FBS 
Table S2. Growth conditions for all cell types utilized. All MSC cultures use MSC GM for all experiments, 
except when noted.   
 
Gene Description  Symbol 
Lineage 
Marker 
0.1 kPa 
MSC 
1 kPa 
MSC 
11 kPa 
MSC 
34 kPa 
MSC 
1 kPa 
MSC 
11 kPa 
MSC 
34 kPa 
MSC 
11 kPa 
MSC 
34 kPa 
MSC 
Inhibitors Added              Bleb  Bleb  Bleb     
(Normalization)     
Actin, 
MSC 
Actin, 
MSC 
Actin, 
MSC 
Actin, 
MSC 
Actin, 
MSC 
Actin, 
MSC 
Actin, 
MSC 
Actin, 
C2C12 
Actin, 
hFOB 
Microtubule-Assoc Prot. Tau  MAPT  N  5.56  7.63  3.70  1.51  1.45  0.88  1.02     
Tau Tubulin Kinase 1  TTBK1  N  5.23  7.28  4.40  1.89  1.62  1.38  1.09     
Tau Tubulin Kinase 2  TTBK2  N  3.56  4.89  3.50  1.74  1.29  0.97  0.93     
Tubulin, Alpha 3  TUBA3  N  1.97  1.25  0.94  0.64  1.11  0.55  0.46     
Tubulin, Beta 1  TUBB1  N  8.41  8.88  5.13  1.50  3.63  1.85  1.26     
Tubulin, Beta 3  TUBB3  N  5.70  3.73  1.49  1.17  1.62  1.02  0.86     
Tubulin, Beta 4  TUBB4  N  8.55  9.67  3.98  0.79  3.42  1.46  0.94     
Glial Der. Neurotrophic Fctr  GDNF  N  9.88  9.67  2.65  1.15  2.18  1.38  1.20     
GDNF Receptor Alpha 1  GFRA1  N  5.14  5.29  2.01  1.16  1.45  1.15  1.02     
N-Cadherin  CDH2  N  2.19  4.70  6.38  1.62  1.52  1.58  1.14     
TNF Receptor Member 5  CD40  N  3.73  6.51  3.72  2.10  1.82  1.39  1.24     
TNF Receptor, Member 6  FAS  N  4.41  6.62  4.21  2.07  2.38  1.71  1.01     
Brain-Der. Neurotrophic Fctr  BDNF  N  4.27  5.72  1.14  1.35  2.52  1.09  1.18     
Neurofilament Light Chain  NEFL  N  3.62  4.13  2.00  1.23  1.97  0.93  0.86     
Internexin Neuronal IFα  INA  N  6.53  6.17  2.52  1.33  2.13  0.64  0.79     
Nerve Growth Factor Beta  NGF  N  4.48  4.46  2.33  1.75  1.20  0.66  0.94     
Neuregulin 1  NRG1  N  4.38  4.67  2.97  1.58  2.12  1.15  0.95     
Signal Activator of Transcrpt. 3  STAT3  N  4.57  5.41  2.07  1.64  1.56  0.73  0.98     
Nestin  NES  N  3.30  4.25  1.38  2.22  1.27  0.44  0.96     
Neural CAM 1  NCAM1  N  7.57  4.55  2.58  2.45  2.33  1.58  1.73     
Integrin, Beta 3  ITGB3  N  0.59  0.72  0.58  0.56  0.78  0.59  0.55     
Paired Box Gene 3  PAX3  M  2.45  2.56  6.96  1.60  0.90  2.49  0.97  0.56   
Paired Box Gene 7  PAX7  M  3.56  3.01  9.40  2.14  0.83  2.60  1.58  0.59   
Myogenic Factor 3  MYOD1  M  2.09  2.20  6.15  1.64  1.14  2.08  1.02  0.58   
Myogenic Factor 4  MYOG  M  2.49  3.48  11.63  1.96  1.15  2.68  0.94  0.59   
Myogenic Factor 5  MYF5  M  2.08  2.82  6.17  1.90  0.71  1.87  1.02  0.65   
Myogenic Factor 6  MYF6  M  2.26  3.50  7.02  2.33  0.77  1.61  1.25  0.76   
Mesenchyme Homeobox 2  MEOX2  M  5.52  6.08  8.81  2.44  1.36  2.08  0.97  0.46   
Forkhead Box K1  FOXK1  M  2.45  2.55  5.12  2.15  1.36  1.97  1.04  0.59   
Myostatin  GDF8  M  3.94  3.21  6.09  2.02  1.16  2.40  1.04  0.67   
MADS Enhancer Factor 2A  MEF2A  M  6.30  3.68  6.23  2.37  1.42  2.52  1.64  0.62   
MADS Enhancer Factor 2B  MEF2B  M  2.83  1.75  7.17  1.89  1.05  2.62  1.01  0.53   
MADS Enhancer Factor 2C  MEF2C  M  2.44  1.69  9.16  2.38  1.03  2.68  1.06  0.57   
MADS Enhancer Factor 2D  MEF2D  M  1.24  1.00  4.29  1.70  0.93  1.37  1.08  0.57   
Growth Fctr Bound Rcptr. 2  GRB2  M  2.20  2.41  6.28  2.63  1.04  2.27  1.16  0.64   
Desmin  DES  M  2.18  2.34  5.13  2.03  1.08  2.83  1.11  0.46   
Msh Homeobox Homolog 1  MSX1  M  1.48  1.57  4.33  1.65  0.98  1.77  0.94  0.63   
Msh Homeobox Homolog 2  MSX2  M  0.70  0.71  1.58  1.08  0.82  1.15  0.81  1.00   
Ladybird H-box Homolog 1  LBX1  M  1.94  1.99  5.08  1.97  0.84  2.03  0.94  0.66   
Nebulin-Rel. Anchoring Prot  NRAP  M  2.47  1.87  8.15  3.52  0.91  2.35  1.66  0.58   
Myotilin  TTID  M  2.08  1.13  5.09  1.58  0.92  2.04  1.04  0.67   
Titin  TTN  M  2.30  1.19  7.40  4.07  0.92  2.51  1.10  0.65   
M-Cadherin  CDH15  M  2.79  2.29  8.46  2.73  1.14  1.93  1.34  0.75   
Integrin, Beta 1D  ITGB1D  M  0.35  0.40  1.22  0.85  0.82  1.04  0.85  0.54   
Integrin, Alpha 7  ITGA7  M  0.28  0.41  1.69  1.03  0.98  1.24  0.96  0.55   
Core Binding Factor Alpha 1  CBFA1  O  0.93  1.31  2.16  2.89  0.93  0.90  1.42    0.37 
Cadherin 11, Type 2  CDH11  O  0.56  0.54  0.90  1.55  0.63  0.88  1.23    0.69 
Osteopontin  SPP1  O  1.25  0.83  1.91  2.61  0.83  1.04  1.23    0.36 
Tuftelin Interact’g Protein 11  TFIP11  O  1.26  0.79  2.87  2.62  0.04  0.70  1.26    0.48 
Twist Homolog 1  TWIST1  O  1.47  1.06  2.16  3.73  0.98  1.08  1.36    0.43 
Twist Homolog 2  TWIST2  O  1.95  1.96  4.94  5.53  0.97  1.19  2.56    0.49 
Sex Det. Region Y-box 9  SOX9  O  1.92  2.64  2.67  2.69  1.48  1.27  1.35    0.32 
SMAD, Mothers Against DPP 1  SMAD1  O  1.74  2.39  3.26  7.23  1.36  1.37  2.89    0.81 
SMAD, Mothers Against DPP 2  SMAD2  O  2.17  2.38  3.11  3.25  1.08  1.41  1.47    0.36 
SMAD, Mothers Against DPP 3  SMAD3  O  2.17  2.73  2.89  2.85  0.96  1.01  1.13    0.34 
SMAD, Mothers Against DPP 4  SMAD4  O  2.06  1.92  3.94  2.68  0.91  1.10  1.80    0.44 
SMAD, Mothers Against DPP 5  SMAD5  O  2.53  2.50  4.11  5.85  0.97  1.81  2.13    0.43 
SMAD, Mothers Against DPP 6  SMAD6  O  3.73  5.39  4.94  6.80  1.06  1.45  2.89    0.42 
SMAD, Mothers Against DPP 7  SMAD7  O  2.53  3.96  2.53  6.06  0.99  1.24  3.43    0.50 
SMAD, Mothers Against DPP 9  SMAD9  O  2.61  3.49  2.51  2.89  0.87  1.13  2.52    0.36   
Vitamin D receptor  VDR  O  2.70  3.32  3.32  3.24  1.18  1.42  1.99    0.42 
Osteocalcin  BGLAP  O  3.36  5.13  4.99  12.03  0.92  1.30  2.94    0.48 
Bone Morpho. Protein 1  BMP1  O  3.81  5.43  4.20  3.46  1.10  1.84  3.07    0.41 
Bone Morpho. Protein 2  BMP2  O  2.23  3.29  2.50  2.78  1.09  1.88  2.57    0.43 
Bone Morpho. Protein 3  BMP3  O  3.34  5.08  3.05  4.09  1.02  2.09  2.68    0.44 
Bone Morpho. Protein 4  BMP4  O  2.91  5.61  3.81  3.38  1.25  1.99  2.96    0.54 
Bone Morpho. Protein 5  BMP5  O  2.67  5.38  2.79  3.78  1.19  1.79  2.93    0.63 
Bone Morpho. Protein 6  BMP6  O  1.76  3.53  1.20  2.41  0.89  1.23  1.75    0.54 
Bone Morpho. Protein 7  BMP7  O  1.91  2.89  2.06  2.09  0.89  1.09  1.87    0.45 
Bone Morpho. Protein 8B  BMP8B  O  1.62  3.27  2.11  2.15  0.96  1.62  1.52    0.49 
Bone Morpho. Protein Rcptr 1A  BMPR1A  O  1.72  2.86  1.60  1.71  0.93  1.13  1.33    0.64 
Matrix Gla Protein  MGP  O  1.91  2.54  1.63  1.46  1.43  1.02  1.67    0.68 
Collagen, Type 1, Alpha 1  COL1A1  O  0.78  0.96  0.51  1.09  0.99  0.78  1.08    1.00 
Collagen, Type 1, Alpha 2  COL1A2  O  0.69  0.89  0.42  1.00  0.99  1.22  1.32    1.00 
Collagen, Type 3, Alpha 1  COL3A1  O  3.67  4.88  2.32  2.35  1.20  1.61  2.13    0.71 
Table S3. Expression of neurogenic (N), myogenic (M), and osteogenic (O) genes in MSCs cultured on 0.1, 
1, 11, and 34 kPa matrices (with and without blebbistatin treatment) was assayed using an oligonucleotide 
array. Data was normalized to actin levels and compared to gene expression of low (4) passage MSCs 
([MSC  on  specific  gel]/MSC).  Values  displayed  represent  relative  fold  changes  from  initially  isolated 
MSCs. mRNA expression for MSCs cultured on 11 and 34 kPa matrices (with and without blebbistatin 
treatment) was also expressed as a fraction of mRNA expression in C2C12 myoblasts or hFOB osteoblasts 
for those indicated genes, and range between 0 (i.e.- no expression) and 1 (i.e. – full expression at positive 
control cell levels).  
 
 
Gene Description  Symbol 
Lineage 
Marker 
0.1 kPa 
MSC 
1 kPa 
MSC 
11 kPa 
MSC 
34 kPa 
MSC 
1 kPa 
MSC 
11 kPa 
MSC 
34 kPa 
MSC 
Inhibitors Added              Bleb  Bleb  Bleb 
(Normalization)      Actin  Actin  Actin  Actin  Actin  Actin  Actin 
Myosin IA  MYO1A  Myo  0.52  0.69  1.38  1.19  0.69  1.07  0.90 
Myosin IIIB  MYO3B  Myo  1.80  1.79  3.88  2.42  0.48  0.62  0.51 
Myosin VB  MYO5B  Myo  0.40  0.50  1.46  1.32  0.71  1.25  0.87 
Myosin IXa  MYO9A  Myo  1.52  1.72  2.57  1.69  0.51  0.63  0.47 
Myosin VI  MYO6  Myo  1.53  1.67  2.28  1.83  0.00  0.02  0.03 
Myosin Light Chain III  MYL6  Myo  0.72  0.67  0.92  1.01  0.69  0.97  0.74 
Myosin Heavy Chain IIa  MHC2a  Myo  1.15  1.92  4.03  3.01  0.05  0.22  0.12 
Sk. Muscle Myosin Heavy III  MYH3  Myo  3.80  3.93  4.69  2.84  0.46  0.75  0.56 
Non-Muscle Myosin IIA  NMM2A  Myo  0.63  0.70  1.12  1.01  0.21  0.29  0.27 
Non-Muscle Myosin IIB  NMM2B  Myo  4.06  3.81  6.69  2.45  0.02  0.08  0.01 
Non-Muscle Myosin IIC  NMM2C  Myo  2.17  2.24  2.95  1.96  0.01  0.06  0.00 
hMyosin Light Chain IIB  HML2B  Myo  1.20  1.37  2.53  1.73  0.54  0.65  0.56 
Talin 1  TLN1  A  0.82  0.86  1.02  1.21  0.54  0.73  0.80 
Filamin C, Gamma  FLNC  A  0.84  0.82  1.04  1.26  0.66  0.98  0.78 
Paxillin  PXN  A  1.31  1.24  1.46  1.68  0.42  0.50  0.46 
Vinculin  VCL  A  4.31  5.53  5.11  4.39  0.38  0.37  0.32 
Laminin, Alpha 2  LAMA2  A  0.98  1.10  1.40  1.09  0.28  0.28  0.29 
Actinin, Alpha 1  ACTN1  A  0.57  0.65  1.25  1.06  0.25  0.52  0.37 
PTK2 Protein Tyrosine Kinase  PTK2  S  0.81  0.82  1.20  1.25  0.38  0.61  0.43 
Ras Homolog A  RHOA  S  0.73  0.86  1.25  1.14  0.28  0.45  0.37 
Ras-C3 Botulinum Substrate 1  RAC1  S  2.64  2.12  1.17  2.82  0.45  0.29  0.54 
Cell Division Cycle 42  CDC42  S  1.48  1.71  1.23  1.56  0.50  0.26  0.49 
Rho-Assoc. Coil-Coil Kinase 1  ROCK1  S  1.17  0.81  1.03  2.15  0.26  0.41  0.59 
Diaphanous Homolog 2  DIAPH2  S  2.99  3.25  4.64  1.79  0.31  0.35  0.29 
Striated Muscle Activator-Rho  STARS  S  1.61  1.56  3.62  0.95  0.69  1.07  0.90 
Table S4. RNA levels for myosin (Myo), adhesion (A), and cell signaling (S) genes were obtained for 
MSCs plated onto 0.1, 1, 11, and 34kPa matrices (with or without blebbistatin) for 7 days. Raw data was 
normalized by total actin levels and ranges from 0 (no expression) to ~1 (maximal expression).    
Supplemental Methods and Text 
 
Creep-Test Micropipette Aspiration  
Micropipettes were forged using a deFonbrune-type microforge (Vibratome; St. Louis, MO) to a radius of 
2–3 µm with an approximately 25
o pipette curvature so when mounted in micromanipulators (Nirishige; 
Japan) at an angle similar to the micropipette’s curvature, the end of the pipette was flush with the cell edge 
(Figure S1A).  A step pressure drop was imposed on the cell membrane, causing the membrane projection, 
L, to aspirate into the pipette as a function of time, t, pressure drop ∆P and pipette radius, R, as governed by 
Sato and coworkers (Sato et al., 1990) viscoelastic half-space model: 
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Images of the projection length were taken every 2 seconds in brightfield on a TE300 inverted Nikon 
microscope and cascade
 CCD camera (Photometrics), which allowed accurate fitting of the parameters κ, 
µ’, and τ to the data to determine each membrane’s elastic and viscous moduli. 
 
Traction Force Measurements  
Displacement fields generated from cell tractions (eg.(Wang et al., 2002) were mapped from embedded 
beads within a soft substratum. Briefly, traction force microscopy uses bead displacements between images 
with and without the adherent cell to assemble a displacement field and determine Green's strain function 
given known material properties of the substratum (elastic modulus, poisson’s ratio, etc). The traction field 
was used to obtain the cell prestress, i.e. –
 the net tensile force through the cell’s cross-sectional area (Wang 
et al., 2002).  
 
 
 
Getting  Physical:    Matrix  Strain  versus  Cellular  Strain  suggests  an  Effective  Energy 
Description for Lineage Specification 
As  a  function  of  matrix  stiffness,  the  two  differentiated  cell  types,  the  C2C12-myoblasts  and 
hFOB-osteoblasts exhibit similar slopes for (κ/E) – though the intercepts are distinct (Fig. 7B, bottom).  By 
using the prestress results (Fig. 7B, top),  these two differentiated cell types have the same slope for (κ/σ) 
(≈ 0.2) that has been reported for highly contractile, smooth muscle cells as assayed by a very different 
technique (Wang et al., 2002). On the other hand, MSCs appear more mechano-sensitive, with twice the 
slope for (κ/E) and (κ/σ).  This increased mechano-sensitivity leads to a self-consistent crossover:  on 
myogenic gels (11 kPa), MSCs and C2C12s have similar κ  whereas on osteogenic gels (34 kPa), MSCs 
and  hFOBs  have  similar  κ .  Despite  the  revealing  difference,  the  inside-outside  relationship  between 
intracellular strains, εin (= σ / κ), and the mean extracellular strain, εout (= τ / E), fits a universal power-law 
for all cell types (Fig. 7, inset).  One can perhaps equate such a strain comparison to comparisons of 
intracellular ion concentrations to extracellular ion concentrations (eg. [Ca
++]in versus [Ca
++]out, etc.).  The 
inverse  relationship  between  intracellular  strains  and  extracellular  strains  here  reveals  that,  on  stiff 
matrices, cell strains are large while matrix strains are small.  In contrast, on soft matrices, cell strains are 
small and  matrix strains are large. The strain  thus transfers from outside to in  with  increasing  matrix 
stiffness, presumably activating different pathways at different strains.  However, the power-law (of form 
εin = B εout
b) found for all cell types implicates a common mechanism, which is consistent with a central 
contractile role in matrix-sensing and response based on non-muscle myosin II (Fig. 7, bottom curves). 
Just as Nernst-type electrochemical equations formalize electrophysiology and help clarify the 
summed  contributions  of  channel  permeabilities,  we  suggest  that  our  findings  here  might  also  be 
formalized  in  a  simple  thermodynamic  model  to  fit  our  differentiation  results  of  Figure  3C.    In 
electrophysiology, the net negative charge of intracellular macro-ions (DNA, protein, etc) is key, whereas 
here the net contractile stress of intracellular myosins (NMMII’s especially) is key.  Instead of the channel 
activity at membranes, the chemomechanical energetics here localize to membrane-matrix adhesions and 
balance the contractile energetics of the cell. We assume two key states for the limiting association of a 
key,  lineage-specific  component  ‘Xi’  which  associates  with  apparent  affinity  K  in  or  near  the  focal   
adhesions and obeys a molecular partition function, ξ, that cooperatively links to collagen (coll) with a Hill 
coefficient m to give: 
  ξ = 1 + [(K/E) coll] 
m  (Eq. S1) 
   
In terms of energetics, K ~ exp(-∆G/kbT) and the matrix modulus E ~ A exp(κx
2/kbT).  Additionally, κ is the 
relevant stiffness of matrix/membrane/adhesions and x is a strain. If κx
2 is small, E ~ A [1 + (κx
2/kbT)] 
which implies that κ is linear in E, as shown in Figure 5B for cortical stiffness. 
We assume that the fraction of unbound Xi matters most for lineage specificity:  θ’ = 1 – [ ∂ ln(ξ) / 
∂ ln(coll)] = 1 / ξ.  This is the free and diffusible fraction of Xi (not associated with collagen) that has the 
strongest effect.  With N as the total number of species Xi, the total unbound portion of this species is  Θ’ = 
N θ’ = N/ξ, which gives a chemomechanical potential for N = constant  as:  
 
  Gchem = -kbT ln(N / ξ) = constant  - kbT ln [ 1 + [(K/E) coll] 
m ]
-1  (Eq. S2) 
 
The free energy depends additionally on the global prestress, σ, assumed to act throughout the cell volume 
V as a global regulator of differentiation. Coupled to this, an increase in free concentration of the local, 
transducing activator/effector links cooperatively to collagen (with Hill coefficient m and affinity K) and to 
matrix stiffness (E) to yield Gtot = Gchem + σV. The net result is a lineage commitment probability given by: 
  





+
− + =
m m m
m
eff B 1 0 lineage
coll K E
E
  T k V exp   a       a      (E) P ) / ( σ   (Eq. S3) 
The effective thermal energy kBTeff  in the exponential should relate more to cytoskeletal stochastics than 
temperature (Lau et al., 2003; Le Goff et al., 2002).  In the limit of rigid substrates with high tensions (σ), 
isometric pulling on adhesions will limit MSC specification, as seen here (Fig. 3C and 4A, B).   
Equation S3 fits the three differentiation peaks of Fig. 3C (at E* ≈ 0.3 kPa, 10 kPa, 30 kPa) with 
best fit values for the key parameters K, m, and Teff determined for peaks at E* ≈ 0.3 kPa, 10 kPa, 30 kPa as 
(K, m, and Teff ):  (2.8·10
-4, 2.4, 9.5·10
-8), (2.2·10
-2, 4.8, 3.4·10
-7) (4.2·10
-2, 8.1, 1.3·10
-6).  .  All of these 
parameters increase with increasing E*, and the cooperativity m notably rises from about 2 to 8 (recall that 
oxygen binds hemoglobin with m ≈ 4), suggesting the progressive formation of large signaling complexes, 
consistent with growing adhesions (Fig. 6A), and increased coupling to the microenvironment.   
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Figure  S1.  Myogenic  Lineage  Commitment  Stops  Short  of  Skeletal  Muscle  Protein 
Expression. (A) Like MSCs spreading on soft matrices and becoming branched, MSCs 
will both actively spread and elongate with time while they stop short of full specification 
as (B) skeletal muscle myosin heavy chain-stained MSCs show minimal expression after 
7 days, regardless of matrix stiffness or media stimulus (not shown). Myoblasts, however, 
show 5- to 10-fold higher expression regardless of matrix mechanics.   
 
Figure S2.  MyoD Regulation by Blebbistatin. MSCs, plated on 11 kPa gels for 24 hr 
prior  to  blebbistatin  addition  (closed  arrow),  were  able  to  maintain  their  spindle 
morphology  (open  points).  MyoD  expression  (closed  points)  was  never  observed  in 
MSCs  continually  treated  with  blebbistatin.  However,  when  blebbistatin  was 
subsequently  washed-out  after  a  72  hr  exposure  (open  arrow),  MyoD  fluorescence 
recovered on a similar time-scale to the initial commitment observed in untreated cells. 
 
 
 
 
 
 
 
 
   
 
Figure  S3.  Cell  Spreading  on  Ultra-Thin  Polyacrylamide  Gel.  Cells  contract  their 
matrices up to 1–3 microns (Wang et al., 2002) so that on thin, soft gels (h ~ 500 nm) 
attached to glass, cells are expected to “feel” a matrix that is effectively stiffer than the 
cast gel.  The result is an enhanced spreading of the cells, which allows mapping the 
spread area on thin gels to that for thick gels and determination of an “apparent” gel 
modulus (inset).  The dark gray shaded region represents the Eapparent, given experimental 
uncertainties.  
 
 
   
 
 
Figure S4. Membrane Cortex Viscoelasticity.  (A) For micropipette aspiration, a curved 
pipette was brought into contact with the side of an adherent cell, a step pressure drop 
aspirated a portion of membrane, and the projection length extending over time is fit to a 
viscoelastic model, Equation 3.  (B) Sample aspiration data of five cells from a single 
matrix stiffness shows the range of variability. Inset images illustrate this phenomenon, 
with arrows indicating the membrane cap. Scale bar is 5 µm.      
 